• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

抑酸药物与胃癌和食管癌风险

Acid inhibitory medication and risk of gastric and oesophageal cancer.

作者信息

McColl K E L

机构信息

Section of Medicine, Gardiner Institute, Western Infirmary, 44 Church Street, Glasgow G11 6NT, UK.

出版信息

Gut. 2006 Nov;55(11):1532-3. doi: 10.1136/gut.2006.103283.

DOI:10.1136/gut.2006.103283
PMID:17047103
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1860103/
Abstract

What are the long term effects of acid suppressive medication on the risk of gastric and oesophageal cancer?

摘要

抑酸药物对胃癌和食管癌风险的长期影响是什么？

相似文献

1
Acid inhibitory medication and risk of gastric and oesophageal cancer.抑酸药物与胃癌和食管癌风险
Gut. 2006 Nov;55(11):1532-3. doi: 10.1136/gut.2006.103283.
2
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.胃酸抑制与食管腺癌和胃腺癌风险：英国一项巢式病例对照研究
Gut. 2006 Nov;55(11):1538-44. doi: 10.1136/gut.2005.086579. Epub 2006 Jun 19.
3
Antacid drug use and risk of esophageal and gastric adenocarcinomas in Los Angeles County.洛杉矶县抗酸药物使用与食管腺癌和胃腺癌风险
Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):526-33. doi: 10.1158/1055-9965.EPI-08-0764. Epub 2009 Feb 3.
4
Risk of cancer and acid suppressant treatment.
Gut. 2007 Jul;56(7):1023. doi: 10.1136/gut.2007.120188.
5
The effect of medications which cause inflammation of the gastro-oesophageal tract on cancer risk: a nested case-control study of routine Scottish data.药物引起的胃食管道炎症对癌症风险的影响：苏格兰常规数据的巢式病例对照研究。
Int J Cancer. 2017 Apr 15;140(8):1828-1835. doi: 10.1002/ijc.30612. Epub 2017 Feb 6.
6
Low-dose aspirin and risk of gastric and oesophageal cancer: A population-based study in the United Kingdom using The Health Improvement Network.低剂量阿司匹林与胃癌和食道癌风险：来自英国健康改善网络的一项基于人群的研究。
Int J Cancer. 2020 Nov 1;147(9):2394-2404. doi: 10.1002/ijc.33022. Epub 2020 May 7.
7
Duration of use of proton pump inhibitors and the risk of gastric and oesophageal cancer.质子泵抑制剂使用时间与胃癌和食管癌风险。
Cancer Epidemiol. 2019 Oct;62:101585. doi: 10.1016/j.canep.2019.101585. Epub 2019 Aug 21.
8
Tamoxifen exposure and risk of oesophageal and gastric adenocarcinoma: a population-based cohort study of breast cancer patients in Sweden.他莫昔芬暴露与食管和胃腺癌风险：瑞典乳腺癌患者的一项基于人群的队列研究。
Br J Cancer. 2006 Jul 3;95(1):118-22. doi: 10.1038/sj.bjc.6603214. Epub 2006 Jun 6.
9
United Kingdom and Ireland Oesophagogastric Cancer Group Cancer Update 2023.
Clin Oncol (R Coll Radiol). 2024 Sep;36(9):e283-e291. doi: 10.1016/j.clon.2024.04.013. Epub 2024 May 24.
10
Risk of esophageal and gastric adenocarcinomas in relation to use of calcium channel blockers, asthma drugs, and other medications that promote gastroesophageal reflux.与使用钙通道阻滞剂、哮喘药物及其他促进胃食管反流的药物相关的食管和胃腺癌风险。
Cancer Epidemiol Biomarkers Prev. 1998 Sep;7(9):749-56.

引用本文的文献

1
Network Pharmacology and Molecular Docking Analysis on Pharmacological Mechanisms of in the Treatment of Gastric Ulcer.关于[药物名称]治疗胃溃疡药理机制的网络药理学与分子对接分析
Evid Based Complement Alternat Med. 2022 Jan 31;2022:9007396. doi: 10.1155/2022/9007396. eCollection 2022.
2
The in vivo preventive and therapeutic properties of curcumin in bile reflux-related oncogenesis of the hypopharynx.姜黄素在胆汁反流相关下咽癌发生发展中的体内预防和治疗作用。
J Cell Mol Med. 2020 Sep;24(18):10311-10321. doi: 10.1111/jcmm.15640. Epub 2020 Jul 21.
3
Why is the coexistence of gastric cancer and duodenal ulcer rare? Examination of factors related to both gastric cancer and duodenal ulcer.为什么胃癌和十二指肠溃疡同时存在的情况很少见？检查与胃癌和十二指肠溃疡都相关的因素。
Gastric Cancer. 2011 Mar;14(1):4-12. doi: 10.1007/s10120-011-0005-9. Epub 2011 Jan 20.
4
Nature meets nurture: molecular genetics of gastric cancer.先天与后天：胃癌的分子遗传学
Hum Genet. 2009 Nov;126(5):615-28. doi: 10.1007/s00439-009-0722-x. Epub 2009 Aug 6.
5
Proton pump inhibitors and risk of gastric cancer: a population-based cohort study.质子泵抑制剂与胃癌风险：一项基于人群的队列研究。
Br J Cancer. 2009 May 5;100(9):1503-7. doi: 10.1038/sj.bjc.6605024. Epub 2009 Apr 7.

本文引用的文献

1
Gastric acidity before and after the development of carcinoma of the stomach.
J Natl Cancer Inst. 1947 Apr;7(5):367-73.
2
Gastric acid suppression and risk of oesophageal and gastric adenocarcinoma: a nested case control study in the UK.胃酸抑制与食管腺癌和胃腺癌风险：英国一项巢式病例对照研究
Gut. 2006 Nov;55(11):1538-44. doi: 10.1136/gut.2005.086579. Epub 2006 Jun 19.
3
Cancer of the esophagus and gastric cardia: recent advances.食管癌和贲门癌：最新进展
Dis Esophagus. 2004;17(1):10-26. doi: 10.1111/j.1442-2050.2004.00371.x.
4
Gastric acidity before and after development of gastric cancer: its etiologic, diagnostic and prognostic significance.胃癌发生前后的胃酸度：其病因学、诊断及预后意义
Ann Intern Med. 1951 Jun;34(6):1331-48. doi: 10.7326/0003-4819-34-6-1331.
5
Hiatal hernia, reflux symptoms, body size, and risk of esophageal and gastric adenocarcinoma.食管裂孔疝、反流症状、体型与食管和胃腺癌风险
Cancer. 2003 Sep 1;98(5):940-8. doi: 10.1002/cncr.11568.
6
Prevalence of Helicobacter pylori in patients with gastro-oesophageal reflux disease: systematic review.胃食管反流病患者中幽门螺杆菌的患病率：系统评价
BMJ. 2003 Apr 5;326(7392):737. doi: 10.1136/bmj.326.7392.737.
7
Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.食管裂孔疝大小、巴雷特食管长度以及胃酸反流的严重程度均为食管腺癌的危险因素。
Am J Gastroenterol. 2002 Aug;97(8):1930-6. doi: 10.1111/j.1572-0241.2002.05902.x.
8
Helicobacter pylori infection and the development of gastric cancer.幽门螺杆菌感染与胃癌的发生
N Engl J Med. 2001 Sep 13;345(11):784-9. doi: 10.1056/NEJMoa001999.
9
Gastric cancer and Helicobacter pylori: a combined analysis of 12 case control studies nested within prospective cohorts.胃癌与幽门螺杆菌：对前瞻性队列中12项病例对照研究的综合分析
Gut. 2001 Sep;49(3):347-53. doi: 10.1136/gut.49.3.347.
10
Gastroesophageal reflux disease, use of H2 receptor antagonists, and risk of esophageal and gastric cancer.胃食管反流病、H2受体拮抗剂的使用与食管癌和胃癌风险
Cancer Causes Control. 2000 Mar;11(3):231-8. doi: 10.1023/a:1008913828105.